Angelos Constantinou

Title: Angelos Constantinou: Innovator in DNA Repair Pathway Inhibitors

Introduction

Angelos Constantinou is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His innovative work focuses on predicting patient responses to DNA repair pathway inhibitors in diffuse large B-cell lymphoma.

Latest Patents

Angelos Constantinou holds a patent for a method that tests whether a patient suffering from large B-cell lymphoma will respond to a DNA repair pathway inhibitor. The patent outlines a comprehensive process that includes determining gene expression levels, calculating a DNA repair score, and comparing this score to predetermined reference values to predict treatment responses.

Career Highlights

Throughout his career, Constantinou has worked with esteemed institutions such as the National Institute of Health and Medical Research and the University of Montpellier. His research has contributed to advancements in understanding and treating complex medical conditions.

Collaborations

He has collaborated with notable colleagues, including Jerome Moreaux and Guillaume Cartron, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Angelos Constantinou's work exemplifies the intersection of innovation and medical research, particularly in improving treatment strategies for cancer patients. His contributions continue to influence the field and offer hope for better patient outcomes.